other material
confidence high
sentiment neutral
materiality 0.70
Elevance Health reaffirms FY2026 adj. EPS at least $25.50, benefit expense ratio ~90.2%
Elevance Health, Inc.
- Reaffirms adjusted shareholders' earnings for FY2026 at least $25.50 per diluted share.
- Reaffirms 2026 benefit expense ratio guidance of 90.2% plus or minus 50 basis points.
- Guidance includes impact of potential CMS sanctions suspending Medicare Advantage enrollment effective March 31, 2026 if not resolved.
- Company cannot provide GAAP reconciliation due to uncertainty over financial payments to resolve CMS matter.